Stallergenes Greer plc – Strategy, SWOT and Corporate Finance Report

Stallergenes Greer plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Stallergenes Greer plc (Stallergenes Greer), formerly Ares Allergy Holdings plc is a biopharmaceutical company, which provides treatments for allergy-related respiratory diseases. The company develops diagnostic tests and products with principal focus on allergies. The company offers treatment for important respiratory diseases, which include severe rhino conjunctivitis and rhinitis, and allergic asthma. Stallergenes Greer provides allergen immunotherapy in various dosage forms including injectable or subcutaneous injections, liquid sublinguals and solid sublinguals. Its research and development activities involve development of candidate products, laboratory research, clinical development and regulatory activities. The company distributes its products to various countries in North America, Europe, Africa; Asia and in Australia. Stallergenes Greer is headquartered in London, the UK.

Scope

Detailed information on Stallergenes Greer plc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Stallergenes Greer plc in the form of a SWOT analysis

An in-depth view of the business model of Stallergenes Greer plc including a breakdown and examination of key business segments

News about Stallergenes Greer plc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Stallergenes Greer plc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Stallergenes Greer plc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Stallergenes Greer plcs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

UCB SA

Meda Pharmaceuticals Inc

Perrigo Company Plc

GlaxoSmithKline Plc

Sanofi

Merck KGaA

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Stallergenes Greer plc - Key Facts 6

Stallergenes Greer plc - Key Employees 7

Stallergenes Greer plc - Key Employee Biographies 8

Stallergenes Greer plc - Major Products and Services 9

Stallergenes Greer plc - History 10

Stallergenes Greer plc - Company Statement 11

Stallergenes Greer plc - Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2 Company Analysis 15

Company Overview 15

Stallergenes Greer plc - Business Description 16

Product Category: Other 16

Overview 16

Performance 16

Product Category: Subcutaneous 16

Overview 16

Performance 16

Product Category: Sublingual 16

Overview 16

Performance 17

Product Category: Veterinary 17

Overview 17

Performance 17

Geographical Segment: International 17

Performance 17

Geographical Segment: Northern and Central Europe 17

Performance 17

Geographical Segment: Southern Europe 17

Performance 17

Geographical Segment: The US 17

Performance 17

R&D Overview 18

Stallergenes Greer plc - SWOT Analysis 19

SWOT Analysis - Overview 19

Stallergenes Greer plc - Strengths 19

Stallergenes Greer plc - Weaknesses 20

Stallergenes Greer plc - Opportunities 21

Stallergenes Greer plc - Threats 22

Stallergenes Greer plc - Key Competitors 23

Section 3 Company Financial Ratios 24

Financial Ratios - Capital Market Ratios 24

Financial Ratios - Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios - Interim Ratios 28

Financial Ratios - Ratio Charts 29

Section 4 Company’s Lifesciences Financial Deals and Alliances 30

Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

Stallergenes Greer plc, Recent Deals Summary 32

Section 5 Company’s Recent Developments 33

Jun 30, 2018: Stallergenes Greer Delivers Double Digit Growth and Solid Business Performance in the First Half of 2018; Announces Senior Leadership Succession Plan 33

Jun 30, 2018: Stallergenes Greer Delivers Double Digit Growth and Solid Business Performance in the First Half of 2018; Announces Senior Leadership Succession Plan 40

Jun 30, 2018: Stallergenes Greer Delivers Double Digit Growth and Solid Business Performance in the First Half of 2018; Announces Senior Leadership Succession Plan 47

Jun 30, 2018: Stallergenes Greer Delivers Double Digit Growth and Solid Business Performance in the First Half of 2018; Announces Senior Leadership Succession Plan 54

Jun 30, 2018: Stallergenes Greer delivers double digit growth and solid business performance in the first half of 2018; announces senior leadership succession plan 61

Jun 07, 2018: Stallergenes Greer Provides Business Update and Refines Its 2018 Financial Outlook 68

Apr 16, 2018: Stallergenes Greer Announces U.S. FDA Approval of Pediatric Indication Extension for Oralair® Sublingual Immunotherapy Tablet for the Treatment of Grass Pollen Allergy 70

Apr 16, 2018: Stallergenes Greer Announces That the Phase III Trial for Its Sublingual Allergy Immunotherapy Tablet STAGR320 to Treat House Dust Mite-Induced Allergic Rhinitis Achieved Its Primary Endpoint 71

Aug 31, 2017: Stallergenes Greer Reports Strong First Half 2017 Results and Narrows 2017 Financial Guidance 74

Jun 29, 2017: Stallergenes Greer Announces Matthias Vogt as Chief Financial Officer 77

Section 6 Appendix 78

Methodology 78

Ratio Definitions 78

About GlobalData 82

Contact Us 82

Disclaimer 82

List of Tables

List of Tables

Stallergenes Greer plc, Key Facts 6

Stallergenes Greer plc, Key Employees 7

Stallergenes Greer plc, Key Employee Biographies 8

Stallergenes Greer plc, Major Products and Services 9

Stallergenes Greer plc, History 10

Stallergenes Greer plc, Subsidiaries 13

Stallergenes Greer plc, Key Competitors 23

Stallergenes Greer plc, Ratios based on current share price 24

Stallergenes Greer plc, Annual Ratios 25

Stallergenes Greer plc, Annual Ratios (Cont…1) 26

Stallergenes Greer plc, Interim Ratios 28

Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

Stallergenes Greer plc, Recent Deals Summary 32

Currency Codes 78

Capital Market Ratios 78

Equity Ratios 79

Profitability Ratios 79

Cost Ratios 80

Liquidity Ratios 80

Leverage Ratios 81

Efficiency Ratios 81

List of Figures

List of Figures

Stallergenes Greer plc, Performance Chart (2014 – 2017) 27

Stallergenes Greer plc, Ratio Charts 29

Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports